TScan Therapeutics Inc.

11/05/2024 | Press release | Distributed by Public on 11/05/2024 09:35

TScan Therapeutics Announces Upcoming Oral Presentation of Data from the ALLOHA™ Phase 1 Heme Trial at the 66th American Society of Hematology Annual Meeting and Exposition